SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents-Reference-Cited by-同舟云学术

SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents

Published:2022-04-01 Issue:4 Volume:8 Page:612
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Fenioux Charlotte¹²,Teixeira Luis³,Fourati Slim¹⁴,Melica Giovanna¹⁵,Lelievre Jean Daniel¹⁵,Gallien Sebastien¹⁵,Zalcman Gérard⁶,Pawlotsky Jean Michel¹⁴,Tournigand Christophe¹²

Affiliation:

1. University Paris Est Créteil, INSERM U955, IMRB, Créteil, France

2. AP-HP, Hôpital Henri Mondor, Service d’oncologie médicale, Créteil, France

3. University de Paris, AP-HP, Hôpital Saint-Louis, Breast Disease Center, INSERM U976, Paris, France

4. AP-HP, Hôpital Henri Mondor, Service de virologie, Créteil, France

5. AP-HP, Hôpital Henri Mondor, Service d’immunologie clinique et maladies infectieuses, Créteil, France

6. Université de Paris, AP-HP, Hôpital Bichat-Claude Bernard, Service d’oncologie thoracique and CIC INSERM 1425, Paris, France

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2788011/jamaoncology_fenioux_2022_br_210021_1650482127.71103.pdf

Reference16 articles.

1. Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER).;Tougeron;Eur J Cancer,2021

2. Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer.;Barrière;Eur J Cancer,2021

3. Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer.;Goshen-Lago;JAMA Oncol,2021

4. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients.;Kamar;N Engl J Med,2021

5. Caring for our cancer patients in the wake of COVID-19.;El-Shakankery;Br J Cancer,2020

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody response to three‐dose anti‐SARS‐CoV‐2 mRNA‐vaccination in treated solid cancer patients;International Journal of Cancer;2023-12-15

2. COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period;Turkish Journal of Medical Sciences;2023-12-12

3. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer;Vaccines;2023-10-19

4. Immunogenicity after two and three doses of mRNA vaccine in patients with cancer treated with exclusive radiotherapy;International Immunopharmacology;2023-09

5. Predictive factors of delayed viral clearance of asymptomatic Omicron-related COVID-19 screened positive in patients with cancer receiving active anticancer treatment;International Journal of Infectious Diseases;2023-07